Liquent Regulatory Solutions for Life Sciences

Home > Information Products > AdComm Bulletin

Read it first. Read it fast.

The AdComm Bulletin is a comprehensive summary of selected U.S. FDA drugs and biologics Advisory Committee Meetings emailed to you moments after the meetings end. Comprised of regulatory, clinical, and marketing information, these succinct and timely reports offer a balanced view of all issues discussed at the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) meetings.

Why Read It?

• Helps you effectively prepare with your own dealings with the FDA
• Enables your company to keep up with your competitors' progress
• Provides insight into the Advisory Committee's direction to the FDA on current clinical practices and what is realistic in clinical design
• Gives you a feel for the voting process within each Advisory Committee
• Provides contextual hyperlinks to the IDRAC database for current IDRAC On-line subscribers
• Dramatically reduces the time, effort and expense required for you to find this level of information

Who Should Read It?

• Directors of Regulatory Affairs
• Managers of Worldwide Affairs
• Medical Directors
• Quality Control Managers
• Compliance Managers
• Directors of Clinical Research
• Clinical Researchers
• Business and Finance Investors
• Legal Departments

And anyone whose profession relies on competitive intelligence gathering and insight into the United States drug approval process

The AdComm Bulletin is provided as part of IDRAC's US Module. Other unique features of IDRAC's US Module include:

• AdComm Profiles – FDA Advisory Committee member information
• AdComm Voting – An overall summary of each FDA Advisory Committee member's voting at committee meetings
• FDA Workshop Bulletin – Coverage of FDA drug and biologic public workshops
• Product Approval Bulletin – Summary of select FDA drug and biologic approvals

For complete information about IDRAC email us at idrac-info@thomson.com

Exclusive Partnership

Liquent is a proud partner of Video on Location Inc. who brings you video coverage of FDA Advisory Committee Meetings. For more information go to www.fdalive.com